News
New Clinical Evidence Confirms
the Efficacy of Active Folate in Anemia
25 September 2024
New Clinical Evidence Confirms
The role of healthcare is crucial, especially considering the high prevalence of undiagnosed iron deficiency and anemia among women of childbearing age who cannot tolerate oral iron supplements.
A combination of iron and active folate, such as Quatrefolic®, offers a valuable alternative for managing iron deficiency when traditional oral iron is not well-tolerated.
In a recent study, researchers aimed to assess the effectiveness and tolerance of three different doses of an iron-whey protein formulation in women of childbearing age who have iron deficiency and experience intolerance to oral iron supplements.
The study found that Iron-Whey Protein (IWP) supplements of up to 50 mg per day were well-tolerated and that higher doses ranging from 60-90 mg effectively improved iron levels and reduced fatigue in this group.
Active Folate is a vital nutrient for the development of healthy red blood cells.
Folate deficiency anemia can manifest without any noticeable symptoms, or it may cause feelings of fatigue, dizziness, pale skin, and heart palpitations.
Quatrefolic®, a form of active folate, has been recognized by the European Food Safety Authority (EFSA) for its beneficial effects in supporting normal blood formation and red blood cell production.
This recognition highlights the importance of adequate folate intake, achieved through dietary sources or targeted supplementation with Quatrefolic®, to maintain optimal red blood cell health and prevent folate deficiency anemia.
